TrialAdvances in therapy2025

Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial.

Horst-Dieter Hummel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.